Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Stem Cell Culture01:17

Stem Cell Culture

6.6K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

610
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
610

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous lesions with Cryptococcus-like changes in the context of ANCA vasculitis: case reports and literature review.

Clinical rheumatology·2026
Same author

Effect of Fiber and Metal Reinforcement on the Flexural Properties of Printed and Conventional Provisional Restorative Materials.

Polymers·2026
Same author

Genomic epidemiology of carbapenemase-producing <i>Klebsiella pneumoniae</i> circulating in a Chilean tertiary-care hospital (2021-2022): Molecular characterization, resistance-virulence convergence, and clinical associations.

Microbial cell (Graz, Austria)·2026
Same author

Trends and drivers of multidrug-resistant bacteria incidence in 59 Chilean intensive care units, 2015-2024: a Bayesian hierarchical analysis.

Lancet regional health. Americas·2026
Same author

Bioeconomy and Climate Change: The Scenarios of Food Insecurity in Brazil's Northern Region (Amazon) Due to the Shift from Traditional Table Crops to Globally Valued Commodities.

Foods (Basel, Switzerland)·2025
Same author

Estimating the Effective Population Size Across Space and Time in the Critically Endangered Western Chimpanzee in Guinea-Bissau: Challenges and Implications for Conservation Management.

Evolutionary applications·2025
Same journal

Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care.

Heart failure clinics·2026
Same journal

Long-term Complications of Pulmonary Embolism: Which Is the Optimal Follow-Up?

Heart failure clinics·2026
Same journal

Recent Advances in Pulmonary Hypertension Management.

Heart failure clinics·2026
Same journal

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension.

Heart failure clinics·2026
Same journal

Portopulmonary Hypertension: Current Perspectives.

Heart failure clinics·2026
Same journal

Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.

Heart failure clinics·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

7.1K

Stem cell therapy for heart failure.

Amit N Patel1, Francisco Silva1, Amalia A Winters1

  • 1University of Utah School of Medicine, 30 North 1900 East 3c127 SOM, Salt Lake City, UT 84132, USA.

Heart Failure Clinics
|April 4, 2015
PubMed
Summary
This summary is machine-generated.

Cell therapy shows promise for heart failure treatment by improving blood vessels and reducing scar tissue, rather than regenerating heart muscle cells. Further large-scale trials are needed to confirm its full potential.

Keywords:
Clinical trialsDeliveryHeart failureStem cell

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.5K

Related Experiment Videos

Last Updated: Apr 15, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

7.1K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.5K

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Heart failure is a significant clinical challenge with limited treatment options.
  • Recent research suggests cell therapy may offer a novel therapeutic approach for heart failure.
  • Existing treatments focus on managing symptoms and slowing disease progression.

Purpose of the Study:

  • To review the current evidence on cell therapy for heart failure.
  • To elucidate the potential mechanisms underlying the therapeutic effects of cell therapy.
  • To identify future research directions for optimizing cell-based treatments.

Main Methods:

  • Review of preclinical animal studies and human clinical trials.
  • Analysis of proposed mechanisms including angiogenesis and fibrosis reduction.
  • Evaluation of different cell types and delivery methods.

Main Results:

  • Cell therapy has demonstrated positive effects in both animal models and human studies of heart failure.
  • Therapeutic benefits appear to be mediated by promoting angiogenesis (new blood vessel formation) and reducing cardiac fibrosis (scarring).
  • Evidence suggests improved cardiac function in failing hearts due to increased microvasculature and decreased scar tissue.

Conclusions:

  • Cell therapy holds significant therapeutic potential for heart failure.
  • The benefits are likely achieved through paracrine effects, such as stimulating blood vessel growth and reducing scar tissue, rather than direct myocyte regeneration.
  • Future research should focus on large-scale, randomized clinical trials with objective endpoints to fully establish efficacy and optimize treatment strategies.